ADMA vs RMD · P/E 22, rev $238.9M vs P/E 29, rev $5.65B
ADMA Biologics Inc (ADMA) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the ADMA and RMD stock pages for the full models.
Not investment advice.